The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE launches annual award to honour changemakers
Sharjah Police recovers AED 500,000 in stolen goods in under 3 hours
UAE welcomes Gaza agreement for Hamas disarmament
Sheikh Abdullah meets UK Foreign Secretary in London
H.H. Sheikh Hamdan attends GCC joint military drill in Bahrain
